Parallel to finishing her PhD in epidemiology and health systems management at the University of Basel, Anna also studied medicine and conducted research at Harvard and the University of Zurich medical schools. She made history as the first female director at Hirslanden Klinik, where she served in leadership for nearly a decade. Before taking on her role as medical director at Hirslanden, she attended executive courses at Harvard Business School and completed the International Directors Program at INSEAD. In addition to mentoring at ETH Zurich and serving as faculty at the University of St. Gallen Executive School, she gives talks on sustainable health, preventive medicine, and longevity for organizations such as the UN and the World Economic Forum.

Guénolé has a diverse background in anesthesiology, emergency medicine and human performance. His contributions to the longevity community reflect his vision for a world where longevity aligns with optimal health, a place where every heartbeat resonates with a life well-lived. Motivated by a desire to redefine the nexus of longevity and healthcare, Guénolé lives by his motto, “Chaque jour compte” – every day counts, emphasizing that health is a continuous journey, not merely a destination. As a medical doctor, he leverages his knowledge to transcend traditional medical practices by integrating advanced genetic testing, biological age assessments, blood biomarkers, and biohacking devices into tailor-made health optimization plans. His approach is focused on prevention and empowerment, aiming to shift the healthcare paradigm from disease treatment to proactive health management, guiding individuals in taking charge of their well-being. Beyond the white coat, he is an aspiring jazz pianist, a big fan of mountaineering and rock climbing, and a sailor, who thrives on the adventurous winds of competitions like the “Vendée Globe”. Why? Because purpose and passion are essential ingredients for longevity!

Thierry works at Oracle Corporation where he represents and coordinates the Insight, Innovation, Industry and Enterprise Architecture teams for EMEA South, Switzerland, Austria and the Scandinavian countries. Before joining Oracle, Thierry worked at McKinsey & Company in Europe, North America and Africa and was a visiting researcher at NEC Tokyo. Prior to that he worked for two Swiss banks in the IT and strategy departments. He holds a Ph.D. in Computer Science and Artificial Intelligence from the University of Zurich and an M.Sc. in Computer Science from ETH Zurich. In his spare time, he spends as much time as possible with his family and outdoors (e.g. training for triathlons), or he programs web and machine learning applications.

Andrew is a retired Olympic athlete and Digital Health and Human Performance Technology Entrepreneur. Currently Andrew works as the Chief Product Officer for Prenetics EMEA. Having competed internationally for 15 years on Team GB, Andrew then went on to win an Olympic bronze medal for the 4x400m relay at the Beijing 2008 Olympic Games. As Andrew’s competitive career came to a close, he joined the founding team of personal genetics company DNAfit, building the world’s first digital platform to help everybody understand how their DNA impacts exercise, nutrition, stress and sleep response. After DNAfit was acquired by the Prenetics group in 2018, Andrew helped grow the EMEA business from a startup to a team of over 700, culminating in a successful Nasdaq listing at >$1bn valuation in 2022.